Ticarcillin-clavulanate as an alternative to imipenem-cilastatin.
Sesin
G P
GP
Gannon
P
P
Mucciardi
N
N
D001424:Bacterial Infections / Q000188:drug therapy*; D015377:Cilastatin / Q000627:therapeutic use; D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D013982:Ticarcillin / Q000627:therapeutic use
D002969:Clavulanic Acids; D011480:Protease Inhibitors; D015377:Cilastatin; D019818:Clavulanic Acid; D015378:Imipenem; D013982:Ticarcillin